Geneva Capital Management LLC Has $183.39 Million Stake in Exponent, Inc. (NASDAQ:EXPO)

Geneva Capital Management LLC increased its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,590,804 shares of the business services provider's stock after acquiring an additional 27,339 shares during the period. Exponent comprises about 3.1% of Geneva Capital Management LLC's holdings, making the stock its 4th largest holding. Geneva Capital Management LLC owned approximately 3.14% of Exponent worth $183,388,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of EXPO. Quarry LP bought a new position in Exponent during the 2nd quarter valued at approximately $25,000. GAMMA Investing LLC raised its position in Exponent by 67.7% during the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider's stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its position in Exponent by 166.5% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider's stock valued at $49,000 after purchasing an additional 323 shares during the last quarter. USA Financial Formulas bought a new position in Exponent during the 3rd quarter valued at approximately $60,000. Finally, Benjamin F. Edwards & Company Inc. raised its position in Exponent by 70.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider's stock valued at $83,000 after purchasing an additional 361 shares during the last quarter. Institutional investors own 92.37% of the company's stock.

Exponent Stock Down 1.3 %

Shares of NASDAQ:EXPO traded down $1.42 during trading on Tuesday, hitting $104.81. The stock had a trading volume of 25,319 shares, compared to its average volume of 245,291. Exponent, Inc. has a 12 month low of $68.70 and a 12 month high of $115.75. The company has a market capitalization of $5.32 billion, a PE ratio of 51.32 and a beta of 0.69. The firm's fifty day moving average is $107.60 and its 200 day moving average is $101.90.

Exponent Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be paid a $0.28 dividend. The ex-dividend date is Friday, December 6th. This represents a $1.12 annualized dividend and a dividend yield of 1.07%. Exponent's payout ratio is currently 54.11%.

Insider Buying and Selling

In related news, Director Paul R. Johnston sold 14,000 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the sale, the director now owns 80,742 shares in the company, valued at $8,445,613.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other Exponent news, Director Paul R. Johnston sold 14,000 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the sale, the director now directly owns 80,742 shares in the company, valued at approximately $8,445,613.20. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now owns 5,871 shares in the company, valued at approximately $565,494.72. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Separately, Truist Financial reissued a "buy" rating and issued a $120.00 target price (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.